Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.
Lindsey KR, Gritz L, Sherry R, Abati A, Fetsch PA, Goldfeder LC, Gonzales MI, Zinnack KA, Rogers-Freezer L, Haworth L, Mavroukakis SA, White DE, Steinberg SM, Restifo NP, Panicali DL, Rosenberg SA, Topalian SL.
Lindsey KR, et al. Among authors: gritz l.
Clin Cancer Res. 2006 Apr 15;12(8):2526-37. doi: 10.1158/1078-0432.CCR-05-2061.
Clin Cancer Res. 2006.
PMID: 16638862
Free PMC article.
Clinical Trial.